New drug combo shows promise against rare, aggressive thyroid cancer
NCT ID NCT05696548
First seen Apr 25, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This study tests whether combining two drugs, nivolumab and lenvatinib, can shrink or control anaplastic thyroid cancer that cannot be removed by surgery. It involves 51 adults with this rare and fast-growing cancer. The main goals are to check safety and see how many patients' tumors shrink significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC THYROID CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aichi Cancer Center
Nagoya, Aichi-ken, 464-8681, Japan
-
Hokkaido University Hospital
Hokkaido, Hokkaido, 060-8648, Japan
-
Hyogo Cancer Center
Akashi, Hyōgo, 673-8558, Japan
-
Kobe University Hospital
Kobe, Hyōgo, 650-0017, Japan
-
National Cancer Center Hospital
Tokyo, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
Nippon Medical School Hospital
Tokyo, Tokyo, 113-8603, Japan
-
Osaka Metropolitan University Hospital
Osaka, Osaka, 545-8586, Japan
-
Tohoku University Hospital
Sendai, Miyagi, 980-8574, Japan
-
Yokohama City University Hospital
Yokohama, Kanagawa, 236-0004, Japan
Conditions
Explore the condition pages connected to this study.